Literature DB >> 11368158

Characterization of high-affinity binding between gangliosides and amyloid beta-protein.

T Ariga1, K Kobayashi, A Hasegawa, M Kiso, H Ishida, T Miyatake.   

Abstract

The binding specificities of amyloid beta-protein (A beta) such as A beta 1-40, A beta 1-42, A beta 40-1, A beta 1-38, A beta 25-35, and amyloid beta precursor protein (beta-APP) analogues for different glycosphingolipids were determined by surface plasmon resonance (SPR) using a liposome capture method. A beta 1-42, A beta 1-40, A beta 40-1, and A beta 1-38, but not A beta 25-35, bound to GM1 ganglioside in the following rank order: A beta 1-42 > A beta 40-1 > A beta 1-40 > A beta 1-38. The beta-APP analogues bound to GM1 ganglioside with a relatively lower affinity. Aged derivatives of A beta were found to have higher affinity to GM1 ganglioside than fresh or soluble derivatives. A beta 1-40 bound to a number of gangliosides with the following order of binding strength: GQ1b alpha > GT1a alpha > GQ1b > GT1b > GD3 > GD1a = GD1b > LM1 > GM1 > GM2 = GM3 > GM4. Neutral glycosphingolipids had a lower affinity for A beta 1-40 than gangliosides with the following order of binding strength: Gb4 > asialo-GM1 (GA1) > Gb3 > asialo-GM2 (GA2) = LacCer. The results seem to indicate that an alpha2,3NeuAc residue on the neutral oligosaccharide core is required for binding. In addition, the alpha2-6NeuAc residue linked to GalNAc contributes significantly to binding affinity for A beta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368158     DOI: 10.1006/abbi.2001.2304

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  51 in total

1.  Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13.

Authors:  Mike P Williamson; Yu Suzuki; Nathan T Bourne; Tetsuo Asakura
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

Review 2.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

3.  Exploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.

Authors:  Christopher B Cowan; Dhara A Patel; Theresa A Good
Journal:  J Theor Biol       Date:  2009-02-13       Impact factor: 2.691

Review 4.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

5.  Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes.

Authors:  Soyon Hong; Beth L Ostaszewski; Ting Yang; Tiernan T O'Malley; Ming Jin; Katsuhiko Yanagisawa; Shaomin Li; Tim Bartels; Dennis J Selkoe
Journal:  Neuron       Date:  2014-03-27       Impact factor: 17.173

Review 6.  Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.

Authors:  Michael B Dinkins; Guanghu Wang; Erhard Bieberich
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease.

Authors:  Anna Colell; Anna Fernández; José C Fernández-Checa
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

8.  Early changes in the apparent diffusion coefficient (ADC) in a mouse model of Sandhoff's disease occur prior to disease symptoms and behavioral deficits.

Authors:  Lingyun Hu; Yingying Sun; Laura E Villasana; Richard Paylor; Eric Klann; Robia G Pautler
Journal:  Magn Reson Med       Date:  2009-11       Impact factor: 4.668

9.  Cytotoxic effects of G(M1) ganglioside and amyloid β-peptide on mouse embryonic neural stem cells.

Authors:  Makoto Yanagisawa; Toshio Ariga; Robert K Yu
Journal:  ASN Neuro       Date:  2010-03-15       Impact factor: 4.146

10.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.